Evidence map›Paper›PMID 40332286›Full record

ArticleMacromolecular rapid communications2025

Synthesis of Aldehyde Functional Polydimethylsiloxane as a New Precursor for Aliphatic Imine-Based Self-Healing PDMS.

Mickaël Du Fraysseix, Simon Lewandowski, Sophie Perraud, Stéphane Carlotti, Audrey Llevot

Abstract read
In one paragraph

Article in Macromolecular rapid communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mickaël Du FraysseixDPHY, ONERA, Université de Toulouse, Toulouse, 31000, France.
Simon LewandowskiDPHY, ONERA, Université de Toulouse, Toulouse, 31000, France.
Sophie PerraudCNES-French Aerospace Agency, 18 avenue Edouard Belin, Toulouse, F-31401 Cedex 9, France.
Stéphane CarlottiUniv. Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629, Pessac, F-33600, France.
Audrey LlevotUniv. Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629, Pessac, F-33600, France.ORCID https://orcid.org/0000-0001-5977-2564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of a simple synthetic route to aldehyde functional poly(dimethylsiloxane) (PDMS) through oxidative C─C bond cleavage of terminal epoxide functions by periodic acid is presented first. Nuclear Magnetic Resonance (NMR) and Infrared spectroscopies revealed the full conversion of the PDMS terminal epoxides to aldehyde groups. This new aldehyde functional PDMS is then used to elaborate aliphatic self-healing materials through imine chemistry by reaction with an amine-terminated PDMS featuring urea moieties in its structure. The reactivity of the aldehyde terminated PDMS is investigated through the preparation of supramolecular networks formed by the hydrogen bonds of ureas. The incorporation of permanent chemical cross-linking points through reaction with a triisocyanate leads to the preparation of covalent adaptable networks (CANs). As a result, materials with a wide range of mechanical properties are obtained, depending on the composition and structure of the PDMS networks. Due to the presence of dynamic covalent imine bonds, the supramolecular networks show excellent scratch recovery at room temperature while the CANs retain their mechanical properties after two cycles of reshaping by heating.

Indexed as

AldehydesDimethylpolysiloxanesIminesHydrogen BondingMolecular StructureAldehydesbaysilonDimethylpolysiloxanesIminesaliphatic aldehydecovalent adaptable networkimine chemistryPoly(dimethylsiloxane)self‐healing material

Identifiers

PMID40332286
PMCPMC12687704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.